Skip to main content
SpringerLink
Log in

Albumin in Critical Care — Use, Abuse, or Misuse

  • Conference paper
Anaesthesia, Pain, Intensive Care and Emergency Medicine — A.P.I.C.E.

  • 335 Accesses

Abstract

Albumin is a small highly symmetric, slightly heterogeneous protein weighing 67,000 daltons with a high cysteine content, composed of a single chain of 584 amino acids with a quaternary helix-like structure. The center of the molecule is made up of hydrophobic radicals, which are binding sites for many ligands. The outer part of the molecule is composed of hydrophilic radicals. Albumin is a relatively small protein in terms of space, but its size is sufficient to prevent it from crossing the capillary membrane [1].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Peters Jr (1985) The serum albumin. Adv Protein Chem 37: 161–245

    Article  PubMed  CAS  Google Scholar 

  2. Sgouris JT, Rene A eds (1976) Proceedings of the workshop on albumin, 1975. National Heart and Lung Institute, US Dept of Heath, Education, and Welfare Publication NIH, Bethesda, Maryland, pp 876–925

    Google Scholar 

  3. Tullis JL (1977) Albumin. Background and use. JAMA 237: 355–360

    Article  PubMed  CAS  Google Scholar 

  4. Watkins S, Madison J, Galliano M et al (1994) Analbuminemia: three cases resulting from different point mutations in the albumin gene. Proc Natl Acad Sci U S A 91: 9417–9421

    Article  PubMed  CAS  Google Scholar 

  5. Falkenberg C, Bjork L, Akerstrom B (1992) Localization of the binding site for streptococcal proteins G on human serum albumin. Identification of a 5.5-kilodalton protein G binding albumin fragment. Biochemistry 31: 14551–14557

    Article  Google Scholar 

  6. Kistler P, Nitschmenn HS (1962) Large-scale production of human plasma fractions. Vox Sang 7: 414–424

    Article  PubMed  CAS  Google Scholar 

  7. Burnouf T, Huart JJ (1994) Human albumin: toxicological and viral safety. Arch Public Health 52: 331–345

    Google Scholar 

  8. Laxenaere MC, Charpentier C, Feldman L (1994) Anaphylactoid reactions to colloid plasma substitutes: incidence, risk factors mechanisms. A French multicenter prospective study. Ann Fr Anesth Reanim 13: 301–310

    Article  Google Scholar 

  9. Goldwasser P, Feldman J (1997) Association of serum albumin and mortality risk. J Clin Epidemiol 50: 693–703

    Article  PubMed  CAS  Google Scholar 

  10. Grootendorst AF, vanWilgenburg MG, de Laat PH et al (1988) Albumin abuse in intensive care medicine. Intensive Care Med 14: 554–557

    Article  PubMed  CAS  Google Scholar 

  11. James WPT, Hay AM (1988) Albumin metabolism: effect of albumin supplementation during parenteral nutrition on hospital morbidity. Crit Care Med 16: 1177–182

    Article  Google Scholar 

  12. Erstad BL, Gales B, Rappaport WD (1991) The use of albumin in clinical practice. Arch Intern Med 151: 901–911

    Article  PubMed  CAS  Google Scholar 

  13. Swisher SN (ed) (1980) Report of Panel 6 on Safety and Efficacy of Blood and Blood Derivatives. Bureau of Biologies, Food and Drug Administration. The Federal Register

    Google Scholar 

  14. Grundmann R, Heistermann S (1985) Postoperative albumin infusion therapy based on colloid osmotic pressure. Arch Surg 120: 911–915

    Article  PubMed  CAS  Google Scholar 

  15. Foley EF, Borlase BC, Dzik WH et al (1990) Albumin supplementation in the critically ill. Arch Surg 125: 739–742

    Article  PubMed  CAS  Google Scholar 

  16. Stockwell MA, Soni N, Riley B (1992) Colloid solutions in the critically ill: a randomised comparison of albumin and polygeline. 1. Outcome and duration of stay in the intensive care unit. Anaesthesia 47: 3–6

    Article  PubMed  CAS  Google Scholar 

  17. Stockwell MA, Scott A, Day A et al (1992) Colloid solutions in the critically ill. A randomized comparison of albumin and polygeline. 2. Serum albumin concentration and incidences of pulmonary oedema and acute renal failure. Anaesthesia 47: 7–9

    Article  PubMed  CAS  Google Scholar 

  18. Cochrane Injuries Group Albumin Reviewers (1998) Human albumin administration in critically ill patients: systematic review of randomised controlled trials. BMJ 317: 235–239

    Article  Google Scholar 

  19. Monafo WW (1996) Initial management of burns. N Engl J Med 335: 1581–1586

    Article  PubMed  CAS  Google Scholar 

  20. Warden GD (1996) Fluid resuscitation and early management. Total Burn Care 53–60

    Google Scholar 

  21. Schlagintweit S, Snelling CGT, German E et al (1990) Major burns managed without blood or blood products. J Burn Care Rehabil 11: 214

    Article  PubMed  CAS  Google Scholar 

  22. Gore DC, Dalton JM, Gehr TW (1996) Colloid infusions reduce glomerular filtration in resuscitated burn victims. J Trauma 40: 356–360

    Article  PubMed  CAS  Google Scholar 

  23. Vermeulen LC, Ratko TA, Erstad BL et al (1995) A paradigm for consensus. The university hospital consortium guidelines for the use of albumin, nonprotein colloid and crystalloid solutions. Arch Intern Med 155: 373–379

    Article  PubMed  Google Scholar 

  24. Yim JM, Vermeulen LV, Erstad BI et al (1995) Albumin and non protein colloid solution use in US academic health centers. Arch Intern Med 155: 2450–2455

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. F. Mercuriali
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. Inghilleri
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Dept. of Clinical Sciences, Section of Anaesthesia, Intensive Care and Pain Clinic, Trieste University Medical School, Trieste, Italy

    Antonino Gullo M.D. (Head) (Head)

Rights and permissions

Reprints and permissions

Copyright information

© 2001 Springer-Verlag Italia

About this paper

Cite this paper

Mercuriali, F., Inghilleri, G. (2001). Albumin in Critical Care — Use, Abuse, or Misuse. In: Gullo, A. (eds) Anaesthesia, Pain, Intensive Care and Emergency Medicine — A.P.I.C.E.. Springer, Milano. https://doi.org/10.1007/978-88-470-2903-3_84

Download citation

  • DOI: https://doi.org/10.1007/978-88-470-2903-3_84

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-88-470-0136-7

  • Online ISBN: 978-88-470-2903-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation